Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Jokubaitis, Vilija G ^a   Gresle, Melissa M ^a   Kemper, Dennis A ^a   Doherty, William ^a   Perreau, Victoria M ^a   Cipriani, Tania L ^a   Jonas, Anna ^a   Shaw, Gerry ^b,c   Kuhlmann, Tanja ^d   Kilpatrick, Trevor J ^a   Butzkueven, Helmut ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c EnCor Biotechnology Inc   (United States)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Dab2; Disabled 2; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuroinflammation

Indexed keywords

EID: 85005765066     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-1-32     Document Type: Article

References (49)

1. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999,122(Pt 12):2279-2295.
2. Bjartmar C, Wujek JR, Trapp BD: Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003,206(2):165-171. 10.1016/S0022-510X(02)00069-2
3. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998,338(5):278-. 10.1056/NEJM199801293380502
4. Gertler FB, Bennett RL, Clark MJ, Hoffmann FM: Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 1989,58(1):103-113. 10.1016/0092-8674(89)90407-8
5. Howell BW, Gertler FB, Cooper JA: Mouse disabled (mDab1): a Src binding protein implicated in neuronal development. Embo J 1997,16(1):121-132. 10.1093/emboj/16.1.121
6. Becker KG, Mattson DH, Powers JM, Gado AM, Biddison WE: Analysis of a sequenced cDNA library from multiple sclerosis lesions. J Neuroimmunol 1997,77(1):27-38. 10.1016/S0165-5728(97)00045-3
7. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX: Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene 1999,18(20):3104-3113. 10.1038/sj.onc.1202649
8. Morris SM, Tallquist MD, Rock CO, Cooper JA: Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport. Embo J 2002,21(7):1555-1564. 10.1093/emboj/21.7.1555
9. Xu XX, Yang W, Jackowski S, Rock CO: Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the drosophila disabled gene product. J Biol Chem 1995,270(23):14184-14191. 10.1074/jbc.270.23.14184
10. Maurer ME, Cooper JA: Endocytosis of megalin by visceral endoderm cells requires the Dab2 adaptor protein. J Cell Sci 2005,118(Pt 22):5345-5355.
11. Yang DH, Smith ER, Roland IH, Sheng Z, He J, Martin WD, Hamilton TC, Lambeth JD, Xu XX: Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis. Dev Biol 2002,251(1):27-44. 10.1006/dbio.2002.0810
12. Mishra SK, Keyel PA, Hawryluk MJ, Agostinelli NR, Watkins SC, Traub LM: Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. Embo J 2002,21(18):4915-4926. 10.1093/emboj/cdf487
13. Morris SM, Cooper JA: Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2001,2(2):111-123. 10.1034/j.1600-0854.2001.020206.x
14. Rosenbauer F, Kallies A, Scheller M, Knobeloch KP, Rock CO, Schwieger M, Stocking C, Horak I: Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion. Embo J 2002,21(3):211-220. 10.1093/emboj/21.3.211
15. Moon C, Lee J, Ahn M, Shin T: Involvement of disabled-2 protein in the central nervous system inflammation following experimental cryoinjury of rat brains. Neurosci Lett 2005,378(2):88-91. 10.1016/j.neulet.2004.12.016
16. Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H: Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. J Neurosci Res 2008,86(16):3548-3555. 10.1002/jnr.21803
17. Herrero-Herranz E, Pardo LA, Gold R, Linker RA: Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 2008,30(2):162-173. 10.1016/j.nbd.2008.01.001
18. Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H: Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med 2009,15(6):626-632. 10.1038/nm.1975
19. Kim SU, de Vellis J: Microglia in health and disease. J Neurosci Res 2005,81(3):302-313. 10.1002/jnr.20562
20. Muzio L, Martino G, Furlan R: Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia. J Neuroimmunol 2007,191(1-2):39-44.
21. Prunier C, Howe PH: Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). J Biol Chem 2005,280(17):17540-17548. 10.1074/jbc.M500974200
22. Jain N, Nguyen H, Friedline RH, Malhotra N, Brehm M, Koyanagi M, Bix M, Cooper JA, Chambers CA, Kang J: Cutting edge: Dab2 is a FOXP3 target gene required for regulatory T cell function. J Immunol 2009,183(7):4192-4196. 10.4049/jimmunol.0902041
23. Zhuang Y, Gudas LJ: Overexpression of COUP-TF1 in murine embryonic stem cells reduces retinoic acid-associated growth arrest and increases extraembryonic endoderm gene expression. Differentiation 2008,76(7):760-771. 10.1111/j.1432-0436.2007.00258.x
24. Chlon TM, Taffany DA, Welsh J, Rowling MJ: Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells. J Nutr 2008,138(7):1323-1328.
25. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W: Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002,125(Pt 10):2202-2212.
26. Ahn M, Oh H, Lee W, Kim H, Moon C, Shin T: Immunohistochemical studies on disabled-2 protein in the spinal cords of rats with experimental autoimmune encephalomyelitis. Brain Res 2011, 1416: 51-60.
27. Gibbons HM, Dragunow M: Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res 2006,1084(1):1-15. 10.1016/j.brainres.2006.02.032
28. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE: Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993,151(4):2132-2141.
29. Acar G, Idiman F, Idiman E, Kirkali G, Cakmakci H, Ozakbas S: Nitric oxide as an activity marker in multiple sclerosis. J Neurol 2003,250(5):588-592. 10.1007/s00415-003-1041-0
30. Ibragic S, Sofic E, Suljic E, Avdagic N, Bajraktarevic A, Tahirovic I: Serum nitric oxide concentrations in patients with multiple sclerosis and patients with epilepsy. J Neural Transm 2012,119(1):7-11. 10.1007/s00702-011-0686-6
31. Liu JS, Zhao ML, Brosnan CF, Lee SC: Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 2001,158(6):2057-2066. 10.1016/S0002-9440(10)64677-9
32. Smith KJ, Lassmann H: The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002,1(4):232-241. 10.1016/S1474-4422(02)00102-3
33. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, Koprowski H: Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci U S A 1995,92(26):12041-12045. 10.1073/pnas.92.26.12041
34. De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P: Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997,56(1):10-20. 10.1097/00005072-199701000-00002
35. Oleszak EL, Zaczynska E, Bhattacharjee M, Butunoi C, Legido A, Katsetos CD: Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin Diagn Lab Immunol 1998,5(4):438-445.
36. Wu Q, Butzkueven H, Gresle M, Kirchhoff F, Friedhuber A, Yang Q, Wang H, Fang K, Lei H, Egan GF, Kilpatrick TJ: MR diffusion changes correlate with ultra-structurally defined axonal degeneration in murine optic nerve. Neuroimage 2007,37(4):1138-1147. 10.1016/j.neuroimage.2007.06.029
37. Lassmann H, van Horssen J: The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 2011,585(23):3715-3723. 10.1016/j.febslet.2011.08.004
38. Haider L, Fischer MT, Frischer JM, Bauer J, Hoftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H: Oxidative damage in multiple sclerosis lesions. Brain 2011,134(Pt 7):1914-1924.
39. Spittau B, Wullkopf L, Zhou X, Rilka J, Pfeifer D, Krieglstein K: Endogenous transforming growth factor-beta promotes quiescence of primary microglia in vitro. Glia 2013,61(2):287-300. 10.1002/glia.22435
40. Xu J, Storer PD, Chavis JA, Racke MK, Drew PD: Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. J Neurosci Res 2005,81(3):403-411. 10.1002/jnr.20518
41. Shankaran M, Marino ME, Busch R, Keim C, King C, Lee J, Killion S, Awada M, Hellerstein MK: Measurement of brain microglial proliferation rates in vivo in response to neuroinflammatory stimuli: application to drug discovery. J Neurosci Res 2007,85(11):2374-2384. 10.1002/jnr.21389
42. Dheen ST, Jun Y, Yan Z, Tay SS, Ling EA: Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 2005,50(1):21-31. 10.1002/glia.20153
43. Butzkueven H, Zhang JG, Soilu-Hanninen M, Hochrein H, Chionh F, Shipham KA, Emery B, Turnley AM, Petratos S, Ernst M, Bartlett PF, Kilpatrick TJ: LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 2002,8(6):613-619. 10.1038/nm0602-613
44. Soilu-Hanninen M, Epa R, Shipham K, Butzkueven H, Bucci T, Barrett G, Bartlett PF, Kilpatrick TJ: Treatment of experimental autoimmune encephalomyelitis with antisense oligonucleotides against the low affinity neurotrophin receptor. J Neurosci Res 2000,59(6):712-721. 10.1002/(SICI)1097-4547(20000315)59:6<712::AID-JNR3>3.0.CO;2-L
45. Gresle MM, Alexandrou E, Wu Q, Egan G, Jokubaitis V, Ayers M, Jonas A, Doherty W, Friedhuber A, Shaw G, Sendtner M, Emery B, Kilpatrick T, Butzkueven H: Leukemia inhibitory factor protects axons in experimental autoimmune encephalomyelitis via an oligodendrocyte-independent mechanism. PLoS One 2012,7(10):e47379. 10.1371/journal.pone.0047379
46. Allen I: Pathology of multiple sclerosis. In McAlpine's Multiple sclerosis. 2nd edition. Edited by: Matthews W. Edinburgh: Churchill Livingstone; 1991:341-378.
47. Lassmann H, Raine CS, Antel J, Prineas JW: Immunopathology of multiple sclerosis: report on an international meeting held at the institute of neurology of the university of vienna. J Neuroimmunol 1998,86(2):213-217. 10.1016/S0165-5728(98)00031-9
48. Bruck W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H: Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995,38(5):788-796. 10.1002/ana.410380514
49. Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ: Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 2006,53(7):696-703. 10.1002/glia.20321